ChartRow logo
Share this page
PeersMRNALLYUNHJNJMRKTMO

Amgen Inc. trailing returns

Amgen Inc.'s 10-year return is +12.5% a year (CAGR) (+225.6% cumulative). How Amgen Inc. (AMGN) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.

Trailing returns by period#

To 2026-10-02. Annualized (CAGR) for windows of a year or more.

PeriodPathAnnualizedCumulative
1 day—-1.0%
5 days—-2.8%
1 month—-9.0%
YTD—+25.7%
1 year
+39.3%
+39.3%
5 years
+17.1%
+120.1%
10 years
+12.5%
+225.6%
20 years
+11.2%
+734.1%
Since inception (1983)
+19.8%
+241966.1%

Growth of AMGN

Actual index level (solid); dashed lines are each window's constant-rate path from start to today.

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from AMGN's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Amgen Inc.'s 10-year return?
Over the last 10 years, Amgen Inc. (AMGN) returned about +12.5% a year annualized (+225.6% cumulative total return).
What is Amgen Inc.'s 20-year annualized return?
Over the last 20 years, Amgen Inc. (AMGN) compounded at about +11.2% a year (+734.1% cumulative).
What is Amgen Inc.'s return since inception?
Since 1983, Amgen Inc. (AMGN) has compounded at about +19.8% a year — +241966.1% in total.

More on Amgen Inc.